Cargando…
Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (COVID-19), a lung disease that may progress to systemic organ involvement and in some cases, death. The identification of the earliest predictors of progressive lung disease would allow for therap...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824252/ https://www.ncbi.nlm.nih.gov/pubmed/33396578 http://dx.doi.org/10.3390/v13010044 |